Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation of the digestive tract. It encompasses two main subtypes: Crohn’s disease and ulcerative colitis. Understanding the etiopathogenesis of IBD and the available pharmacotherapy options is essential for managing the disease effectively. In this article, we will explore the underlying causes and mechanisms of IBD and discuss the pharmacotherapy approaches used in its treatment.
